Oculeve Acquired By Allergan For $125M
South San Francisco-based Oculeve, a medical device company developing treatments for dry eye disease, has been acquired by Dublin, California-based Allergan, the two said this morning. The two said Allergan will pay $125M in an upfront payment, plus unspecified earnout, for Oculeve. Oculeve was venture backed by Kleiner Perkins Caufield & Byers, New Enterprise Associates, and Versant Ventures. Oculeve's lead program is a medical device, OD-01, a non-invasive nasal neurostimulation device that increases tear production in patients with dry eye disease.
posted on Monday, July 6, 2015
Related companies:
Oculeve, Inc.
Related stories:
> MAP Pharmaceuticals Acquired By Allergan
> Tobira Therapeutics Acquired By Allergan For $1.7B
> ZELTIQ Acquired By Allergan For $2.47 Billion
> SuccessFactors Files For $125M IPO
> Oracle Invests $125M in Indian IT Services Firm
silicontap.com Home